Gambaran Umum
RaySearch Laboratories AB, based in Sweden, operates predominantly in the medical technology sector, focusing on software solutions that enhance cancer treatment through precision radiotherapy and oncology care. Central to its offerings is the RayStation, a flexible treatment planning system that supports a multitude of treatment methods, and RayCare, an oncology information system designed to streamline clinical workflows in cancer treatment. The company is also pioneering advancements in proton and carbon ion therapy with its RayCommand system, and AI-driven treatment planning with RayIntelligence. By integrating cutting-edge technology and user-centric designs, RaySearch strives to improve efficiency and outcomes in cancer care globally, maintaining a strong commitment to innovation and collaboration in the medical community.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk RaySearch Laboratories AB (publ) per 2025 Jun 30 adalah 1,252.53 MM.
- Nilai operating income untuk RaySearch Laboratories AB (publ) per 2025 Jun 30 adalah 237.60 MM.
- Nilai net income untuk RaySearch Laboratories AB (publ) per 2025 Jun 30 adalah 192.95 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,252.53 | 237.60 | 192.95 |
2025-03-31 | 1,266.53 | 280.56 | 223.62 |
2024-12-31 | 1,192.03 | 251.50 | 203.51 |
2024-09-30 | 1,169.00 | 238.56 | 175.06 |
2024-06-30 | 1,128.58 | 205.67 | 151.22 |
2024-03-31 | 1,049.19 | 144.57 | 100.71 |
2023-12-31 | 1,022.16 | 122.48 | 81.57 |
2023-09-30 | 986.90 | 78.78 | 64.17 |
2023-06-30 | 944.90 | 62.17 | 52.69 |
2023-03-31 | 865.67 | 24.42 | 22.04 |
2022-12-31 | 843.65 | 30.31 | 23.78 |
2022-09-30 | 767.84 | -5.24 | -6.33 |
2022-06-30 | 693.38 | -43.80 | -38.39 |
2022-03-31 | 687.72 | -46.74 | -35.13 |
2021-12-31 | 641.67 | -64.04 | -47.31 |
2021-09-30 | 612.93 | -22.21 | -45.51 |
2021-06-30 | 595.65 | -25.13 | -49.70 |
2021-03-31 | 604.83 | -13.62 | -42.43 |
2020-12-31 | 651.61 | 25.68 | -9.08 |
2020-09-30 | 726.28 | 14.41 | 24.02 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | 5.11 | 5.11 |
2024-06-30 | 4.41 | 4.41 |
2024-03-31 | 2.94 | 2.94 |
2023-12-31 | 2.38 | 2.38 |
2023-09-30 | 1.88 | 1.87 |
2023-06-30 | 1.54 | 1.53 |
2023-03-31 | 0.64 | 0.64 |
2022-12-31 | 0.69 | 0.69 |
2022-09-30 | -0.18 | -0.18 |
2022-06-30 | -1.13 | -1.13 |
2022-03-31 | -1.02 | -1.03 |
2021-12-31 | -1.38 | -1.38 |
2021-09-30 | -1.31 | -1.31 |
2021-06-30 | -1.44 | -1.44 |
2021-03-31 | -1.24 | -1.23 |
2020-12-31 | -0.26 | -0.26 |
2020-09-30 | 0.71 | 0.71 |
2020-06-30 | 1.24 | 1.24 |
2020-03-31 | 2.15 | 2.15 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk RaySearch Laboratories AB (publ) per 2025 Jun 30 adalah 380.76 MM.
- Nilai cash from investing activities untuk RaySearch Laboratories AB (publ) per 2025 Jun 30 adalah -213.48 MM.
- Nilai kas dari aktivitas pendanaan untuk RaySearch Laboratories AB (publ) per 2025 Jun 30 adalah -181.30 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 380.76 | -213.48 | -181.30 |
2025-03-31 | 464.73 | -218.67 | -160.39 |
2024-12-31 | 485.23 | -217.54 | -159.78 |
2024-09-30 | 498.11 | -221.35 | -146.89 |
2024-06-30 | 556.89 | -219.54 | -144.68 |
2024-03-31 | 469.56 | -218.06 | -57.86 |
2023-12-31 | 455.93 | -209.33 | -56.35 |
2023-09-30 | 456.29 | -197.54 | -71.25 |
2023-06-30 | 334.95 | -180.74 | -78.25 |
2023-03-31 | 348.55 | -192.91 | -59.71 |
2022-12-31 | 320.66 | -201.38 | -72.49 |
2022-09-30 | 232.93 | -209.53 | -39.45 |
2022-06-30 | 282.36 | -235.70 | -24.81 |
2022-03-31 | 259.62 | -237.91 | -90.93 |
2021-12-31 | 238.16 | -237.63 | -72.23 |
2021-09-30 | 261.27 | -240.78 | -93.62 |
2021-06-30 | 292.40 | -240.58 | -93.14 |
2021-03-31 | 369.77 | -225.65 | -45.14 |
2020-12-31 | 331.51 | -225.59 | -44.02 |
2020-09-30 | 361.14 | -222.49 | -47.49 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.11.
- roe untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.29.
- roic untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.16.
- croic untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.05.
- ocroic untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.34.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.11 | 0.29 | 0.16 | 0.05 | 0.34 |
2025-03-31 | 0.10 | 0.26 | 0.15 | 0.09 | 0.36 |
2024-12-31 | 0.09 | 0.24 | 0.14 | 0.09 | 0.39 |
2024-09-30 | 0.08 | 0.21 | 0.12 | 0.15 | 0.44 |
2024-06-30 | 0.15 | ||||
2024-03-31 | 0.12 | ||||
2023-12-31 | 0.05 | 0.16 | |||
2023-09-30 | 0.04 | 0.07 | |||
2023-06-30 | 0.08 | ||||
2023-03-31 | 0.03 | ||||
2022-12-31 | |||||
2022-09-30 | 0.00 | ||||
2022-06-30 | 0.00 | 0.00 | |||
2022-03-31 | 0.00 | ||||
2021-12-31 | 0.00 | 0.00 | |||
2021-09-30 | -0.04 | -0.06 | |||
2021-06-30 | -0.04 | -0.06 | -0.05 | 0.34 | |
2021-03-31 | -0.03 | -0.06 | -0.05 | 0.10 | 0.39 |
2020-12-31 | -0.01 | -0.01 | -0.01 | 0.06 | 0.35 |
2020-09-30 | 0.02 | 0.03 | 0.03 | 0.10 | 0.41 |
2020-06-30 | 0.03 | 0.06 | 0.04 | 0.05 | 0.32 |
2020-03-31 | 0.06 | 0.11 | 0.07 | -0.00 | 0.32 |
Gross Margins
- marjin kotor untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.92.
- marjin bersih untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.18.
- marjin operasi untuk RaySearch Laboratories AB (publ) pada 2025 Jun 30 adalah 0.22.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.92 | 0.18 | 0.22 |
2025-03-31 | 0.92 | 0.17 | 0.22 |
2024-12-31 | 0.91 | 0.15 | 0.20 |
2024-09-30 | 0.90 | 0.13 | 0.18 |
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | 0.06 | 0.07 | |
2023-06-30 | 0.06 | 0.07 | |
2023-03-31 | 0.03 | 0.03 | |
2022-12-31 | |||
2022-09-30 | 0.00 | 0.00 | |
2022-06-30 | 0.00 | 0.00 | |
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | 0.91 | -0.08 | -0.04 |
2021-03-31 | 0.93 | -0.07 | -0.02 |
2020-12-31 | 0.93 | -0.01 | -0.01 |
2020-09-30 | 0.92 | 0.03 | 0.03 |
2020-06-30 | 0.92 | 0.06 | 0.05 |
2020-03-31 | 0.92 | 0.09 | 0.08 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |